We unfortunately cannot accept new PhIP-Seq platform customers at this time. We plan to resume HuScan service in Fall 2022.
High-throughput human autoantibody discovery service.
Our new HuScan™ technology provides epitope-level antibody discovery versus the entire human proteome.
ANTYGEN™ HuScan™ service allows us to analyze patient samples (serum, plasma, CSF, etc.) for the presence of autoantibodies against the full UniProt human proteome in a single-well assay with quantitative sequencing readouts. This product is available as a service to both academic and industry customers.
Contact us to learn more.
Explore the world’s most powerful antigen libraries.